fda vinay prasad - Search News

News

FDA names Dr. Vinay Prasad

Vinay Prasad believes that the FDA too often has acted as a rubber stamp for pharma, both big and small.

Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new challenge in the form of Vinay Prasad, who this week was named to lead the FDA's Center for Biologics Evaluation and Research.

USA TODAY on MSN · 2d

FDA names Dr. Vinay Prasad as top vaccine official

In his new role with the FDA, Dr. Vinay Prasad will oversee the regulation of costly drugs, including vaccines, gene therapies, and blood supply.

CNN on MSN · 2d

FDA chooses Dr. Vinay Prasad to lead biologics, vaccines division

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist, to lead its Center for Biologics Evaluation and Research, the division that oversees vaccines and biologic medicines.

BioPharma Dive1d

Biotech is guessing how Vinay Prasad might change the FDA. His research, writing offer clues.

CBER’s new chief has argued for more stringent measures of assessing drugs for cancer and rare diseases, suggesting he might ...

STAT1d

New CBER Director Vinay Prasad praises evidence, FDA reviewers in first speech to staff

WASHINGTON — In his first address to FDA staff on Wednesday, Vinay Prasad emphasized his commitment to evidence, his ...

New FDA Leadership Could Raise The Bar For Drug Approvals

A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.

2don MSN

The FDA names a new vaccine chief with an unsettling record, joining a controversial team

Dr. Vinay Prasad, the FDA's new vaccine chief, has been accused of spreading misinformation about Covid vaccines.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results